United States Antiviral Drugs Market Size, Share, and COVID-19 Impact Analysis, By Drug Class (Protease Inhibitors, Neuraminidase Inhibitors, DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, and Others), By Type (Generics and Branded), By Application (Herpes, HIV, Influenza, Hepatitis, and Others), By Distribution Channel (Retail Pharmacy, Online Pharmacy, and Hospital Pharmacy), and US Antiviral Drugs Market Insights, Industry Trend, Forecasts to 2035
Premium Report Details
Base Year:
2024
Tables & Figures:
105
Pages:
194
Countries covered:
1
Companies covered::
10
Forecast CAGR:
4.71%
Connect with us
smartphone
smartphone
email
email
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we
also
use cookies to show you personalized ads? Learn
more and manage your cookies